Integra LifeSciences recalls C7000 Console software version 2.1.1.909 due to touch screen unresponsiveness. Affected units have specific serial numbers and model.
“Integra C7000 Console Software Issue: Touch Screen Unresponsive.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/49774-integra-c7000-console-software-issue-touch-screen-unresponsive. Based on FDA recall #Z-1828-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1828-2026%22&limit=1).
Integra LifeSciences Corp. (NeuroSciences) recalled CUSA Clarity C7000 consoles with software version 2.1.1.909 due to a touch screen rendering unresponsive, the FDA said on March 6, 2026.
How to tell if you have it
Brand: Integra NeuroSciences
Product: CUSA Clarity C7000 Console, Ultrasonic surgical aspirator system
The software issue renders the touch screen unresponsive, according to the FDA.
Context
GovInfoNow's records show Integra LifeSciences Corp. (NeuroSciences) has 12 other recalls on record since April 4, 2025. Other recent recalls of similar products include Integra LifeSciences OmniTract Surgical Retractor System Recall (June 5, 2026), Codman CerebroFlo EVD Catheter Recall (April 10, 2026), and Integra Cytal Wound Matrix 2-Layer 10x15 cm recall (March 19, 2026). Other recent recalls of similar products include Fresenius Kabi Ivenix Infusion Pump Recall (May 6, 2026) and Medtronic Restore CP App Model A71100 Software Issue (Nov. 20, 2025).
How to tell if you have this one
Check for the model C7000 with serial numbers listed in the recall notice. The software version must be 2.1.1.909 to be affected.
Brand
Integra NeuroSciences
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Software Version
Verify the software version on the console; if it is 2.1.1.909, it is affected.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 2 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide - US Nationwide distribution in the states of MI & NY. The countries of Belgium, China, Czechia, Dubai, Finland, France, Germany, Italy, Japan, Luxembourg, Netherlands. Poland, Spain, Switzerland, Tunisia & United Kingdom.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Michigan, New York.
Recall timeline
FDA published this recall 54 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1828-2026 (March 6, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1828-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.